FindTrial
Sign In

Study for the clinical plan of integrated traditional Chinese and conventional medicine in the treatment of pancreatic neoplasm

Study for the clinical plan of integrated traditional Chinese and conventional medicine in the treatment of pancreatic neoplasm

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022632
Enrollment
Unknown
Registered
2019-04-19
Start date
2019-04-20
Completion date
Unknown
Last updated
2019-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic neoplasm

Interventions

Conventional medicine group:routine conventional medicine treatment
Integrated Chinese and conventional medicine Group:routine conventional medicine plus TCM 'Bian-Zhen Lun-Zhi' treatment

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Female aged 18 to 75 years; 2. Stage III-IV pancreatic cancer patients with definite pathological diagnosis and inoperable operation; 3. expected lifetime>=3 months; 4. The ECOG score is 0-2; 5. Voluntary participation in the study, signing informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with serious diseases of heart, liver, kidney and hematopoietic system; (2) Patients known to be allergic to research medications; (3) Children, pregnant women, mental patients and patients with other malignant tumors; (4) Patients undergoing other drug trials.

Design outcomes

Primary

MeasureTime frame
Overall Survival;—

Countries

China

Contacts

Public ContactHua Baojin

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

huabaojin@sohu.com+86 010-88001221

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 20, 2026